Safety	O
and	O
efficacy	O
of	O
tranexamic	B:C0040613
acid	I:C0040613
in	O
bleeding	O
paediatric	O
trauma	I:C3714660
patients	O
:	O
a	O
systematic	O
review	I:C1955832
protocol	O
.	O

Safety	O
and	O
efficacy	O
of	O
tranexamic	O
acid	I:C0040613
in	O
bleeding	B:C0019080
paediatric	O
trauma	I:C3714660
patients	O
:	O
a	O
systematic	O
review	I:C1955832
protocol	O
.	O

Safety	O
and	O
efficacy	O
of	O
tranexamic	O
acid	I:C0040613
in	O
bleeding	O
paediatric	B:C3714660
trauma	I:C3714660
patients	O
:	O
a	O
systematic	O
review	I:C1955832
protocol	O
.	O

Safety	O
and	O
efficacy	O
of	O
tranexamic	O
acid	I:C0040613
in	O
bleeding	O
paediatric	O
trauma	I:C3714660
patients	O
:	O
a	O
systematic	B:C1955832
review	I:C1955832
protocol	O
.	O

Safety	O
and	O
efficacy	O
of	O
tranexamic	O
acid	I:C0040613
in	O
bleeding	O
paediatric	O
trauma	I:C3714660
patients	O
:	O
a	O
systematic	O
review	I:C1955832
protocol	B:C0442711
.	O

Trauma	B:C3714660
is	O
the	O
leading	O
cause	O
of	O
death	O
among	O
children	O
aged	O
1	O
-	O
18	O
.	O

Trauma	O
is	O
the	O
leading	O
cause	O
of	O
death	B:C1306577
among	O
children	O
aged	O
1	O
-	O
18	O
.	O

Studies	O
indicate	O
that	O
better	O
control	O
of	O
bleeding	B:C0019080
could	O
potentially	O
prevent	O
10	O
-	O
20	O
%	O
of	O
trauma	O
-	O
related	O
deaths	O
.	O

Studies	O
indicate	O
that	O
better	O
control	O
of	O
bleeding	O
could	O
potentially	O
prevent	O
10	O
-	O
20	O
%	O
of	O
trauma	B:C3714660
-	O
related	O
deaths	O
.	O

Studies	O
indicate	O
that	O
better	O
control	O
of	O
bleeding	O
could	O
potentially	O
prevent	O
10	O
-	O
20	O
%	O
of	O
trauma	O
-	O
related	O
deaths	B:C1306577
.	O

The	O
antifibrinolytic	B:C0003304
agent	I:C0003304
tranexamic	O
acid	I:C0040613
(	O
tranexamic	O
acid	I:C0040613
)	O
has	O
shown	O
promise	O
in	O
haemorrhage	O
control	O
in	O
adult	O
trauma	O
patients	O
.	O

The	O
antifibrinolytic	O
agent	I:C0003304
tranexamic	B:C0040613
acid	I:C0040613
(	O
tranexamic	O
acid	I:C0040613
)	O
has	O
shown	O
promise	O
in	O
haemorrhage	O
control	O
in	O
adult	O
trauma	O
patients	O
.	O

The	O
antifibrinolytic	O
agent	I:C0003304
tranexamic	O
acid	I:C0040613
(	O
tranexamic	B:C0040613
acid	I:C0040613
)	O
has	O
shown	O
promise	O
in	O
haemorrhage	O
control	O
in	O
adult	O
trauma	O
patients	O
.	O

The	O
antifibrinolytic	O
agent	I:C0003304
tranexamic	O
acid	I:C0040613
(	O
tranexamic	O
acid	I:C0040613
)	O
has	O
shown	O
promise	O
in	O
haemorrhage	B:C0019080
control	O
in	O
adult	O
trauma	O
patients	O
.	O

The	O
antifibrinolytic	O
agent	I:C0003304
tranexamic	O
acid	I:C0040613
(	O
tranexamic	O
acid	I:C0040613
)	O
has	O
shown	O
promise	O
in	O
haemorrhage	O
control	O
in	O
adult	O
trauma	B:C3714660
patients	O
.	O

However	O
,	O
information	O
on	O
the	O
potential	O
benefits	O
of	O
tranexamic	B:C0040613
acid	I:C0040613
in	O
children	O
remains	O
sparse	O
.	O

This	O
review	B:C0282443
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	O
effects	I:C0879626
of	O
tranexamic	O
acid	I:C0040613
in	O
the	O
bleeding	O
paediatric	O
trauma	I:C3714660
population	O
.	O

This	O
review	O
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	B:C0879626
effects	I:C0879626
of	O
tranexamic	O
acid	I:C0040613
in	O
the	O
bleeding	O
paediatric	O
trauma	I:C3714660
population	O
.	O

This	O
review	O
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	O
effects	I:C0879626
of	O
tranexamic	B:C0040613
acid	I:C0040613
in	O
the	O
bleeding	O
paediatric	O
trauma	I:C3714660
population	O
.	O

This	O
review	O
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	O
effects	I:C0879626
of	O
tranexamic	O
acid	I:C0040613
in	O
the	O
bleeding	B:C0019080
paediatric	O
trauma	I:C3714660
population	O
.	O

This	O
review	O
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	O
effects	I:C0879626
of	O
tranexamic	O
acid	I:C0040613
in	O
the	O
bleeding	O
paediatric	B:C3714660
trauma	I:C3714660
population	O
.	O

This	O
review	O
proposes	O
to	O
evaluate	O
the	O
current	O
uses	O
,	O
benefits	O
and	O
adverse	O
effects	I:C0879626
of	O
tranexamic	O
acid	I:C0040613
in	O
the	O
bleeding	O
paediatric	O
trauma	I:C3714660
population	B:C1257890
.	O

A	O
structured	O
search	O
of	O
bibliographic	B:C0079198
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	B:C0025141
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	B:C0079198
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	B:C1138432
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	B:C0079198
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	B:C0079198
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	B:C0206035
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	B:C0040613
acid	I:C0040613
in	O
paediatric	O
trauma	I:C3714660
patients	O
.	O

A	O
structured	O
search	O
of	O
bibliographic	O
databases	I:C0079198
(	O
eg	O
,	O
MEDLINE	O
,	O
EMBASE	O
,	O
PubMed	O
,	O
CINAHL	O
,	O
Cochrane	O
CENTRAL	I:C0079198
)	O
has	O
been	O
undertaken	O
to	O
retrieve	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
and	O
cohort	O
studies	O
that	O
describe	O
the	O
use	O
of	O
tranexamic	O
acid	I:C0040613
in	O
paediatric	B:C3714660
trauma	I:C3714660
patients	O
.	O

After	O
deduplication	O
,	O
citations	B:C0552371
will	O
be	O
screened	O
independently	O
by	O
2	O
authors	O
,	O
and	O
selected	O
for	O
inclusion	O
based	O
on	O
prespecified	O
criteria	O
.	O

After	O
deduplication	O
,	O
citations	O
will	O
be	O
screened	O
independently	O
by	O
2	O
authors	B:C3812881
,	O
and	O
selected	O
for	O
inclusion	O
based	O
on	O
prespecified	O
criteria	O
.	O

Data	B:C1707635
extraction	I:C1707635
and	O
risk	O
of	O
bias	O
assessment	O
will	O
be	O
performed	O
independently	O
and	O
in	O
duplicate	O
.	O

Data	O
extraction	I:C1707635
and	O
risk	O
of	O
bias	O
assessment	B:C0220825
will	O
be	O
performed	O
independently	O
and	O
in	O
duplicate	O
.	O

Meta-analytic	B:C0920317
methods	I:C0920317
will	O
be	O
employed	O
wherever	O
appropriate	O
.	O

This	O
study	O
will	O
not	O
involve	O
primary	O
data	B:C0010995
collection	I:C0010995
,	O
and	O
formal	O
ethical	O
approval	O
will	O
therefore	O
not	O
be	O
required	O
.	O

The	O
findings	O
of	O
this	O
study	O
will	O
be	O
disseminated	B:C0205221
through	O
a	O
peer	O
-	I:C0034036
reviewed	I:C0034036
publication	I:C0034036
and	O
at	O
relevant	O
conference	O
meetings	I:C0586182
.	O

The	O
findings	O
of	O
this	O
study	O
will	O
be	O
disseminated	O
through	O
a	O
peer	B:C0034036
-	I:C0034036
reviewed	I:C0034036
publication	I:C0034036
and	O
at	O
relevant	O
conference	O
meetings	I:C0586182
.	O

The	O
findings	O
of	O
this	O
study	O
will	O
be	O
disseminated	O
through	O
a	O
peer	O
-	I:C0034036
reviewed	I:C0034036
publication	I:C0034036
and	O
at	O
relevant	O
conference	B:C0586182
meetings	I:C0586182
.	O

